This was a phase 4 clinical trial was to evaluate the safety of 1 new 6:2 influenza virus reassortant in adults. The study enrolled 300 healthy adults 18 through 49 years of age at 2 study sites, each site randomizing…

This was a multi-center, placebo-controlled study to compare the efficacy and safety of (study drug) to placebo in subjects with T2DM who had inadequate blood sugar control. Approximately 210 male or female subjects with Type 2 Diabetes were enrolled in…

This was a Phase 3B endpoint study to evaluate the cardiovascular safety of 2 FDA approved gout medications, Allopurinol and Uloric. All patients must have had a diagnosis of both gout and a history of cardiovascular disease. The study enrolled…

This was a Phase 4 trial of an investigational medication for the treatment of Overactive Bladder. The purpose of this study was to evaluate the efficacy, safety and tolerability of (study drug) compared with Placebo in older adult subjects with…

This was a multicenter, 12-week treatment period study to evaluate the safety, tolerability and efficacy of 3 doses of study drug compared to placebo in patients 18 years of age and older with fasting triglyceride levels between 500 mg/dl and…

If you don’t see a study that interests you and you’d like to be contacted about a future study for a particular indication/disease, please provide your contact info and a study coordinator will contact you.